Free Trial

Insider Buying: Primary Health Properties Plc (LON:PHP) Insider Purchases 4,055 Shares of Stock

Primary Health Properties logo with Real Estate background

Primary Health Properties Plc (LON:PHP - Get Free Report) insider Harry Abraham Hyman bought 4,055 shares of the stock in a transaction that occurred on Friday, August 15th. The shares were purchased at an average price of GBX 91 ($1.23) per share, with a total value of £3,690.05 ($5,004.14).

Harry Abraham Hyman also recently made the following trade(s):

  • On Monday, August 11th, Harry Abraham Hyman bought 14,853 shares of Primary Health Properties stock. The shares were purchased at an average price of GBX 95 ($1.29) per share, with a total value of £14,110.35 ($19,135.27).
  • On Monday, August 11th, Harry Abraham Hyman bought 13,360 shares of Primary Health Properties stock. The shares were purchased at an average price of GBX 95 ($1.29) per share, with a total value of £12,692 ($17,211.83).
  • On Friday, August 1st, Harry Abraham Hyman bought 25,660 shares of Primary Health Properties stock. The shares were purchased at an average price of GBX 96 ($1.30) per share, with a total value of £24,633.60 ($33,406.02).

Primary Health Properties Stock Performance

Shares of PHP opened at GBX 92.50 ($1.25) on Monday. The stock has a 50-day simple moving average of GBX 97.50 and a 200-day simple moving average of GBX 96.78. The company has a debt-to-equity ratio of 96.73, a quick ratio of 0.62 and a current ratio of 0.50. The stock has a market capitalization of £1.24 billion, a PE ratio of -144.39, a PEG ratio of 5.64 and a beta of 0.41. Primary Health Properties Plc has a 1 year low of GBX 85.40 ($1.16) and a 1 year high of GBX 105.50 ($1.43).

Primary Health Properties (LON:PHP - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Primary Health Properties had a negative return on equity of 0.61% and a negative net margin of 4.84%. On average, analysts predict that Primary Health Properties Plc will post 7.0875912 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a "buy" rating on shares of Primary Health Properties in a research note on Thursday, August 7th.

Check Out Our Latest Research Report on PHP

About Primary Health Properties

(Get Free Report)

Primary Health Properties plc is a leading investor in modern primary healthcare properties. The Company acquires or forward funds the development of modern, purpose-built premises that are leased to GP's, government healthcare bodies, pharmacies and other providers of related healthcare services.

Featured Stories

Insider Buying and Selling by Quarter for Primary Health Properties (LON:PHP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Primary Health Properties Right Now?

Before you consider Primary Health Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Primary Health Properties wasn't on the list.

While Primary Health Properties currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines